Zobrazeno 1 - 10
of 138
pro vyhledávání: ''
Autor:
Kazuhide Iizuka, Katsuhiro Miura, Tomohiro Nakayama, Masami Takei, Yoshihito Uchino, Masaru Nakagawa, Yoshihiro Hatta, Takashi Hamada, Hiromichi Takahashi, Noriyoshi Iriyama, Kazuya Kurihara, Takashi Koike
Publikováno v:
Medical oncology (Northwood, London, England). 36(9)
The use of bortezomib in the clinic has significantly improved outcomes for patients with multiple myeloma (MM), even those harboring high-risk cytogenetic abnormalities or those classified in the high-risk category according to the International Sta
Autor:
S. V. Saju, Anand Raja, Manikandan Dhanushkodi, Ganesarajah Selvaluxmy, Venkatraman Radhakrishnan, Trivadi S. Ganesan, Tenali Gnana Sagar
Publikováno v:
Medical oncology (Northwood, London, England). 36(3)
Germ cell tumors (GCTs) are one of the most common tumors in adolescents and young adults. There is paucity of data on GCT from low–middle-income countries (LMIC). The present study was conducted to assess the demographic features, clinical manifes
Autor:
Karen E Skinner, Melissa Pavilack, Ancilla W. Fernandes, Kellie Ryan, Mark S. Walker, Noam A. VanderWalde, Rajeshwari S. Punekar
Publikováno v:
Medical oncology (Northwood, London, England). 36(3)
This study examined real-world clinical outcomes such as progression-free survival (PFS), time to metastasis (TTM), overall survival (OS), and health-related quality of life (HRQOL) in patients with unresected stage III non-small cell lung cancer (NS
Autor:
Hayato Yamamoto, Shingo Hatakeyama, Chikara Ohyama, Naoki Fujita, Kazuaki Yoshikawa, Hiroyuki Ito, Atsushi Imai, Kazutaka Okita, Sakae Konishi, Yasuhiro Hashimoto, Takahiro Yoneyama, Takuya Koie
Publikováno v:
Medical oncology (Northwood, London, England). 36(1)
We aimed to investigate the impact of postoperative weight loss following radical cystectomy (RC) on patients’ prognoses. RC and urinary diversion were performed in 512 consecutive patients with muscle-invasive bladder cancer at our hospitals betwe
Autor:
S. Arculeo, Barbara Alicja Jereczek-Fossa, A. Maucieri, Stefania Volpe, S. Parisi, Ombretta Alessandro, Cristiana Fodor, Sara Gandini, Matteo Ferro, Alessia Surgo, Franco Nolè, Dario Zerini, O. De Cobelli, Giulia Marvaso, Andrea Vavassori, Gennaro Musi, Maria Alessia Zerella, Giuseppe Fanetti, Raffaella Cambria, Delia Ciardo, Giulia Riva, Federica Cattani, Cristina Garibaldi, Anna Starzyńska, Roberto Orecchia, Patrick Maisonneuve
Publikováno v:
Medical oncology (Northwood, London, England). 36(1)
To report toxicity and efficacy outcome of moderately hypofractionated image-guided external-beam radiotherapy in a large series of patients treated for prostate cancer (PCa). Between 10/2006 and 12/2015, 572 T1-T3N0M0 PCa patients received 70.2 Gy i
Autor:
Gerald W. Prager, Markus Kieler, Alexandra Kaider, Matthias Unseld, Daniela Bianconi, Johann Wojta, Svitlana Demyanets
Publikováno v:
Medical Oncology (Northwood, London, England)
Interleukin-33 (IL-33) and its “decoy” receptor soluble ST2 (sST2) are involved in the development of chronic inflammation and cancer. We explored IL-33 and sST2 as a potential prognostic marker in patients with metastatic and locally advanced pa
Publikováno v:
Medical oncology (Northwood, London, England). 35(9)
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) represent a heterogeneous group of tumors that is associated with an indolent course. Octreotide has a positive effect on disease stabilization in well-differentiated midgut NETs, but a meanin
Autor:
Adrijana D'Silva, D. Gwyn Bebb, Haocheng Li, S. Otsuka, A. Elegbede, R. Tudor, A. Gibson, Winson Y. Cheung
Publikováno v:
Medical oncology (Northwood, London, England). 35(9)
To assess the impact of location versus number of extra-pulmonary metastatic sites (EPMS) on survival in stage IV non-small cell lung cancer (NSCLC). Retrospective analysis was conducted on patients diagnosed during 1999–2013 with stage IV, M1b (AJ
Autor:
Shiro Imokawa, Naoki Inui, Yusuke Kaida, Yuzo Suzuki, Koji Nishimoto, Kazuhiro Asada, Masato Karayama, Hiroyuki Matsuda, Nao Inami, Tomoyuki Fujisawa, Takafumi Suda, Hironao Hozumi, Hideki Yasui, Yutaro Nakamura, Masato Fujii, Kazuki Furuhashi, Shun Matsuura, Noriyuki Enomoto, Takashi Matsui, Mikio Toyoshima
Publikováno v:
Medical oncology (Northwood, London, England). 35(7)
Switch maintenance therapy, using alternative agents that were not administered during induction chemotherapy, is a treatment option for advanced non-squamous non-small cell lung cancer (NSCLC). Bevacizumab is known to increase the efficacy of other
Autor:
Raffaella Cambria, Roberto Orecchia, S.P. Colangione, Giorgia Timon, Delia Ciardo, Giulia Marvaso, Dario Zerini, Cristiana Fodor, Giulia Riva, Federica Cattani, Sara Gandini, Ottavio De Cobelli, Barbara Alicja Jereczek-Fossa, Stefania Comi
Publikováno v:
Medical oncology (Northwood, London, England). 35(6)
Ultra-hypofractionated radiotherapy (RT) is given over a shorter time with larger doses with respect to conventional fractionation in patients with localized prostate cancer (PCa). The use of hypofractionation is supported both from the radiobiologic